Logo

American Heart Association

  2
  0


Final ID: MDP18

Exome-wide association study of over a million individuals identified effector genes and variants for blood lipids

Abstract Body (Do not enter title and authors here): Background: Inherited hypercholesterolemia is an important Mendelian condition associated with early onset myocardial infarction. However, current genetic diagnostic criteria only partially explain severe clinical hypercholesterolemia. Furthermore, current pathogenicity categorizations do not consistently inform prognosis, but quantification is limited by scarcity of such rare variants.
Aim: Exploiting populations scale genotype/phenotype data, to determine the architecture of the genetic variants associating with blood lipid levels with quantitative assessments.
Methods: Here, we discovered and characterized rare coding alleles contributing to genetic dyslipidemia, a principal risk for coronary artery disease, among over a million individuals combining two large contemporary genetic datasets (Million Veteran Program N = 626,554 and UK Biobank, N = 431,026).
Results: Testing 2,869,269 rare (minor allele frequency < 1%), coding variants, we identified 793 exome-wide significant associations (P < 4.4 × 10-11), including 8 previously undiscovered loci. Associated alleles are highly enriched in functional variant classes; high confidence predicted loss of function, deleterious missense, and cryptic splicing, showed significant and recessive associations, had similar effects across populations. Overall, rare variants contributed to additional > 16% of genetic trait variances on top of common genetic variants. The effect estimates of associated signals confirmed and refined curated pathogenic database, highlighted by the identification of African or South Asian specific pathogenic alleles previously controversial in its pathogenicity.
Conclusion: This study provides resources and insights for understanding causal mechanisms and quantifying the expressivity of rare coding alleles for blood lipids by large scale sequencing study. Furthermore, identifying and characterizing population enriched variants, our study underscored the importance of multi-population rare variant study.
  • Koyama, Satoshi  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Dron, Jacqueline  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Spinks, Catherine  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Surakka, Ida  ( University of Michigan , Ann Arbor , Michigan , United States )
  • Hornsby, Whitney  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Damrauer, Scott  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Chang, Kyong-mi  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Assimes, Themistocles  ( Stanford Univ. School of Medicine , Palo Alto , California , United States )
  • Tsao, Philip  ( STANFORD UNIVERSITY SCHOOL MEDICINE , Stanford , California , United States )
  • Rader, Daniel  ( Univ of Pennsylvania , Philadelphia , Pennsylvania , United States )
  • Kim, Kelly  ( VA Boston Healthcare System-MAVERIC , Northborough , Massachusetts , United States )
  • Yu, Zhi  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Peloso, Gina  ( Boston University School of Public , Boston , Massachusetts , United States )
  • Ellinor, Patrick  ( Massachusetts General Hospital , Boston , Massachusetts , United States )
  • Sun, Yan  ( Emory University , Atlanta , Georgia , United States )
  • Wilson, Peter  ( Emory University , Atlanta , Georgia , United States )
  • Natarajan, Pradeep  ( Massachusetts General Hospital , Brookline , Massachusetts , United States )
  • Choi, Seung Hoan  ( Boston University , Boston , Massachusetts , United States )
  • Jurgens, Sean  ( Broad Institute and Amsterdam UMC , Amsterdam , Netherlands )
  • Selvaraj, Margaret  ( MGH-Boston , North Attleboro , Massachusetts , United States )
  • Klarin, Derek  ( Stanford University , Mountain View , California , United States )
  • Huffman, Jennifer  ( Boston VA Healthcare System , Jamaica Plain , Massachusetts , United States )
  • Trinh, Michael  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Ravi, Akshaya  ( Broad Institute , Cambridge , Massachusetts , United States )
  • Author Disclosures:
    Satoshi Koyama: DO NOT have relevant financial relationships | Jacqueline Dron: DO NOT have relevant financial relationships | Catherine Spinks: DO NOT have relevant financial relationships | Ida Surakka: DO NOT have relevant financial relationships | Whitney Hornsby: No Answer | Scott Damrauer: DO have relevant financial relationships ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Research Funding (PI or named investigator):Renalytix:Past (completed) | Kyong-Mi Chang: No Answer | Themistocles Assimes: DO NOT have relevant financial relationships | Philip Tsao: No Answer | Daniel Rader: DO have relevant financial relationships ; Consultant:Alnylam:Active (exists now) ; Consultant:Verve:Active (exists now) ; Consultant:Novartis:Active (exists now) | Kelly Kim: DO NOT have relevant financial relationships | Zhi Yu: DO NOT have relevant financial relationships | Gina Peloso: DO NOT have relevant financial relationships | Patrick Ellinor: DO have relevant financial relationships ; Research Funding (PI or named investigator):Bayer AG:Active (exists now) ; Research Funding (PI or named investigator):Pfizer:Active (exists now) ; Research Funding (PI or named investigator):BMS:Active (exists now) ; Research Funding (PI or named investigator):Novo Nordisk:Active (exists now) ; Consultant:Bayer AG:Active (exists now) | Yan Sun: DO NOT have relevant financial relationships | Peter Wilson: DO NOT have relevant financial relationships | Pradeep Natarajan: DO have relevant financial relationships ; Researcher:Allelica:Active (exists now) ; Advisor:Preciseli:Active (exists now) ; Advisor:MyOme:Active (exists now) ; Advisor:Esperion Therapeutics:Active (exists now) ; Advisor:TenSixteen Bio:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:Genentech / Roche:Active (exists now) ; Consultant:Eli Lilly & Co:Active (exists now) ; Researcher:Novartis:Active (exists now) ; Researcher:Genentech / Roche:Active (exists now) | Seung Hoan Choi: DO NOT have relevant financial relationships | Sean Jurgens: DO NOT have relevant financial relationships | Margaret Selvaraj: DO NOT have relevant financial relationships | Derek Klarin: DO have relevant financial relationships ; Employee:Bitterroot Bio:Active (exists now) | Jennifer Huffman: No Answer | Michael Trinh: DO NOT have relevant financial relationships | Akshaya Ravi: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Clinical and Translational Studies of Lipoproteins and Lipids in Vascular Diseases

Saturday, 11/16/2024 , 12:50PM - 02:15PM

Moderated Digital Poster Session

More abstracts on this topic:
More abstracts from these authors:
Multi-Omic Profiling of Adiposity Distribution Patterns

Pan Michael, Dron Jacqueline, Schuermans Art, Agrawal Saaket, Fourman Lindsay, Koyama Satoshi, Hornsby Whitney, Peloso Gina, Natarajan Pradeep

Integrative Metabolomic Analysis of Triglyceride-Independent Lipoprotein Lipase Pathway Mechanisms for Coronary Artery Disease

Dron Jacqueline, Xue Liying, Koyama Satoshi, Schuermans Art, Lee Jiwoo, Honigberg Michael, Hornsby Whitney, Peloso Gina, Natarajan Pradeep

You have to be authorized to contact abstract author. Please, Login
Not Available